Display options
Share it on

Ther Adv Musculoskelet Dis. 2017 Apr;9(4):89-95. doi: 10.1177/1759720X17692502. Epub 2017 Feb 14.

The role of vitamin D in maintaining bone health in older people.

Therapeutic advances in musculoskeletal disease

Thomas R Hill, Terry J Aspray

Affiliations

  1. Human Nutrition Research Centre, Newcastle University, Newcastle upon Tyne, UK.
  2. Consultant Physician, Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK, Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne.

PMID: 28382112 PMCID: PMC5367643 DOI: 10.1177/1759720X17692502

Abstract

This review summarises aspects of vitamin D metabolism, the consequences of vitamin D deficiency, and the impact of vitamin D supplementation on musculoskeletal health in older age. With age, changes in vitamin D exposure, cutaneous vitamin D synthesis and behavioural factors (including physical activity, diet and sun exposure) are compounded by changes in calcium and vitamin D pathophysiology with altered calcium absorption, decreased 25-OH vitamin D [25(OH)D] hydroxylation, lower renal fractional calcium reabsorption and a rise in parathyroid hormone. Hypovitaminosis D is common and associated with a risk of osteomalacia, particularly in older adults, where rates of vitamin D deficiency range from 10-66%, depending on the threshold of circulating 25(OH)D used, population studied and season. The relationship between vitamin D status and osteoporosis is less clear. While circulating 25(OH)D has a linear relationship with bone mineral density (BMD) in some epidemiological studies, this is not consistent across all racial groups. The results of randomized controlled trials of vitamin D supplementation on BMD are also inconsistent, and some studies may be less relevant to the older population, as, for example, half of participants in the most robust meta-analysis were aged under 60 years. The impact on BMD of treating vitamin D deficiency (and osteomalacia) is also rarely considered in such intervention studies. When considering osteoporosis, fracture risk is our main concern, but vitamin D therapy has no consistent fracture-prevention effect, except in studies where calcium is coprescribed (particularly in frail populations living in care homes). As a J-shaped effect on falls and fracture risk is becoming evident with vitamin D interventions, we should target those at greatest risk who may benefit from vitamin D supplementation to decrease falls and fractures, although the optimum dose is still unclear.

Keywords: Vitamin D; bone health; older people; osteomalacia; osteoporosis

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

  1. Lancet. 2014 Apr 12;383(9925):1292 - PubMed
  2. J Bone Miner Res. 2013 Oct;28(10):2202-13 - PubMed
  3. Am J Med. 2004 May 1;116(9):634-9 - PubMed
  4. J Clin Densitom. 2006 Jan-Mar;9(1):120-7 - PubMed
  5. Bone. 1986;7(6):421-5 - PubMed
  6. J Clin Invest. 1973 Nov;52(11):2672-81 - PubMed
  7. Age Ageing. 2013 Mar;42(2):186-90 - PubMed
  8. J Bone Miner Res. 2016 Nov;31(11):2024-2031 - PubMed
  9. Arch Osteoporos. 2012;7:155-72 - PubMed
  10. J Clin Endocrinol Metab. 2013 Dec;98(12):E1927-35 - PubMed
  11. South Med J. 2001 Jun;94(6):569-73 - PubMed
  12. BMJ. 2010 Jan 12;340:b5463 - PubMed
  13. J Bone Miner Res. 1991 Feb;6(2):125-32 - PubMed
  14. Rheumatology (Oxford). 2007 Dec;46(12):1852-7 - PubMed
  15. Calcif Tissue Int. 2013 Feb;92(2):118-27 - PubMed
  16. J Bone Miner Res. 2010 Feb;25(2):305-12 - PubMed
  17. Age Ageing. 1984 Jan;13(1):14-20 - PubMed
  18. Maturitas. 2015 Feb;80(2):126-32 - PubMed
  19. Lancet. 1989 Nov 4;2(8671):1104-5 - PubMed
  20. BMJ. 2009 Oct 01;339:b3692 - PubMed
  21. JAMA Intern Med. 2016 Feb;176(2):175-83 - PubMed
  22. Age Ageing. 1980 Nov;9(4):249-52 - PubMed
  23. Lancet. 1970 Sep 12;2(7672):535-7 - PubMed
  24. J Clin Endocrinol Metab. 2012 Oct;97(10):3550-6 - PubMed
  25. Arch Gerontol Geriatr. 2014 Jul-Aug;59(1):78-82 - PubMed
  26. Am J Clin Nutr. 2009 May;89(5):1366-74 - PubMed
  27. Eur J Clin Nutr. 2005 Apr;59(4):533-41 - PubMed
  28. Osteoporos Int. 2013 May;24(5):1769-70 - PubMed
  29. Lancet. 2014 Jan 11;383(9912):146-55 - PubMed
  30. Endocrinology. 2014 Sep;155(9):3210-3 - PubMed
  31. Osteoporos Int. 2016 Mar;27(3):1199-208 - PubMed
  32. JAMA. 2005 May 11;293(18):2257-64 - PubMed
  33. Am J Clin Nutr. 1994 Oct;60(4):619-30 - PubMed
  34. Age Ageing. 2006 Sep;35(5):482-6 - PubMed
  35. J Clin Endocrinol Metab. 2003 Jan;88(1):185-91 - PubMed
  36. JAMA. 2010 May 12;303(18):1815-22 - PubMed
  37. J Clin Endocrinol Metab. 2011 Oct;96(10):3250-6 - PubMed
  38. Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227 - PubMed
  39. J Clin Endocrinol Metab. 1992 Oct;75(4):1099-103 - PubMed
  40. J Clin Invest. 1985 Oct;76(4):1536-8 - PubMed
  41. J Bone Miner Res. 1993 Jul;8(7):779-87 - PubMed
  42. J Clin Endocrinol Metab. 2006 Aug;91(8):2980-5 - PubMed
  43. Osteoporos Int. 2011 Mar;22(3):859-71 - PubMed
  44. Br J Nutr. 2011 Jan;105(1):144-56 - PubMed
  45. J Sci Med Sport. 2015 Sep;18(5):575-80 - PubMed
  46. J Bone Miner Res. 1989 Aug;4(4):469-75 - PubMed
  47. Lancet. 1995 Jul 22;346(8969):207-10 - PubMed
  48. BMJ. 2003 Mar 1;326(7387):469 - PubMed
  49. N Engl J Med. 2012 Jul 5;367(1):40-9 - PubMed
  50. J Intern Med. 2006 Sep;260(3):245-54 - PubMed

Publication Types

Grant support